UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 197

Sortiert nach

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Molecular therapy, 2017-01, Vol.25 (1), p.249-258

2017

Link zum Volltext

Verfügbarkeit prüfen

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Science translational medicine, 2014-06, Vol.6 (242), p.242ra83

2014

Link zum Volltext

Verfügbarkeit prüfen

Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment

Cancer discovery, 2018-08, Vol.8 (8), p.972-987

2018

Link zum Volltext

Verfügbarkeit prüfen

Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients

Current opinion in infectious diseases, 2018-08, Vol.31 (4), p.292-300

2018

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic and functional characterization of posoleucel, a multivirus-specific T cell therapy for the treatment and prevention of viral infections in immunocompromised patients

Cytotherapy (Oxford, England), 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy

British journal of haematology, 2023-08, Vol.202 (4), p.874-878

2023

Link zum Volltext

Verfügbarkeit prüfen

Fine-tuning the CAR spacer improves T-cell potency

Oncoimmunology, 2016-12, Vol.5 (12), p.e1253656-e1253656

2016

Link zum Volltext

Verfügbarkeit prüfen

Antiviral T-cell therapy

Immunological reviews, 2014-03, Vol.258 (1), p.12-29

2014

Link zum Volltext

Verfügbarkeit prüfen

Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

Molecular therapy, 2014-06, Vol.22 (6), p.1211-1220

2014

Link zum Volltext

Verfügbarkeit prüfen

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation

Journal for immunotherapy of cancer, 2018-05, Vol.6 (1), p.34-34, Article 34

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Molecular therapy, 2013-11, Vol.21 (11), p.2113-2121

2013

Link zum Volltext

Verfügbarkeit prüfen

Is cancer gene therapy an empty suit?

The lancet oncology, 2013-10, Vol.14 (11), p.e447-e456

2013

Link zum Volltext

Verfügbarkeit prüfen

Improving T cell therapy for cancer

Annual Review of Immunology, 2007-01, Vol.25 (1), p.243-265

2007

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay

Frontiers in immunology, 2023, Vol.14, p.1299512-1299512

2023

Link zum Volltext

Verfügbarkeit prüfen

Asian Elephant T Cell Responses to Elephant Endotheliotropic Herpesvirus

Journal of virology, 2018-03, Vol.92 (6)

2018

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of Tumor Destruction by Chimeric Antigen Receptor-modified T Cells

Molecular therapy, 2014-03, Vol.22 (3), p.623-633

2014

Link zum Volltext

Verfügbarkeit prüfen

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003237

2021

Link zum Volltext

Verfügbarkeit prüfen

Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing

Cytotherapy (Oxford, England), 2024-03, Vol.26 (3), p.266-275

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and Immunotherapy

Journal of Virology, 2008-01, Vol.82 (1), p.546-554

2008

Link zum Volltext

Verfügbarkeit prüfen

T lymphocytes targeting native receptors

Immunological reviews, 2014-01, Vol.257 (1), p.39-55

2014

Link zum Volltext

Verfügbarkeit prüfen

PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor

Molecular therapy, 2011-12, Vol.19 (12), p.2133-2143

2011

Link zum Volltext

Verfügbarkeit prüfen

Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy

Cytotherapy (Oxford, England), 2019-02, Vol.21 (2), p.212-223

2019

Link zum Volltext

Verfügbarkeit prüfen

Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid Tumors

Cancer immunology research, 2022-11, Vol.10 (11), p.1370-1385

2022

Link zum Volltext

Verfügbarkeit prüfen

Adenovirus as an emerging pathogen in immunocompromised patients

British journal of haematology, 2005-01, Vol.128 (2), p.135-144

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 197

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(141)
Life Sciences & Biomedicine
(135)
Humans
(86)
Female
(36)
Immunotherapy
(36)
Medicine, Research & Experimental
(36)
Research & Experimental Medicine
(36)
Male
(32)
Animals
(30)
Oncology
(26)
Immunology
(23)
Biotechnology & Applied Microbiology
(22)
Lymphocytes
(22)
Antigens
(21)
T-Lymphocytes, Cytotoxic - Immunology
(19)
Cytokines
(18)
Hematology
(18)
Health Aspects
(16)
T Cells
(16)
Biological And Medical Sciences
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT

Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment

Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients

Phenotypic and functional characterization of posoleucel, a multivirus-specific T cell therapy for the treatment and prevention of viral infections in immunocompromised patients

T cell immune profiling of respiratory syncytial virus for the development of a targeted immunotherapy

Fine-tuning the CAR spacer improves T-cell potency

Antiviral T-cell therapy

Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Is cancer gene therapy an empty suit?

Improving T cell therapy for cancer

Assessment of the cytolytic potential of a multivirus-targeted T cell therapy using a vital dye-based, flow cytometric assay

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

Asian Elephant T Cell Responses to Elephant Endotheliotropic Herpesvirus

Kinetics of Tumor Destruction by Chimeric Antigen Receptor-modified T Cells

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer

Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing

Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and Immunotherapy

T lymphocytes targeting native receptors

PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor

Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy

Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid Tumors

Adenovirus as an emerging pathogen in immunocompromised patients

Aktive Filter

Suchergebnisse filtern